Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 543 for “"Liver--Cancer"”.
-
Nitric oxide in Liver Cancer
… (NO) has been implicated in the pathogenesis of liver cancer or hepatocellular carcinoma (HCC). However, the exact role(s) of NO and the expression pattern of its enzymes, nitric oxide synthases (NOS), remain unclear. Thus, this study was designed to investigate the expression and regulation of …
-
Cyanobacterial toxins and liver cancer
… carcinoma (HCC) is the fifth most common cancer in the world today. Over the past decade, the incidence of HCC in Canada has been increasing despite efforts to mitigate disease causing factors such as viral hepatitis B and C infection. Fresh water cyanobacteria are known to release potent …
-
FUNCTIONAL DISSECTION OF ST18 IN LIVER CANCER
… in HCC. However, functional evidence for a cancer-promoting activity of ST18 and insight into its mode of action are missing. Here, I pursued the functional characterization of ST18 in a mouse model of HCC based on ex vivo transformation and subcutaneous transplantation of embryonic …
-
Applying quantitative image analysis to liver cancer
… Carcinoma (HCC) compared to many other cancers, and death rates are increasing in countries such as the United States and United Kingdom. To improve outcomes, tumours need to be detected at a much earlier stage. Magnetic resonance imaging (MRI) may provide a method to detect tumours …
-
Detection of structural variations during liver cancer progression
… carcinoma (HCC) is one of the most lethal cancers in the world and accounts for the vast majority of all liver cancers. HCC develops in response to various factors including viral infections, aflatoxin, alcohol and metabolic diseases. Recent studies have highlighted substantial differences …
-
Biomimetic and vascularized 3-d liver cancer model
… in vitro models, and yet 2D in vitro models of liver cancer co-administered with these two types of drugs show increased cell viability, contradicting clinical trials. In vitro models should mimic clinical trials in order to accurately predict drug outcomes. 2D in vitro models fail because they …
-
Genomic Profiling of Alternative splicing in liver cancer
The development of liver cancers is a multistep process, which is known to progress through diverse molecular and biological mechanisms. Recently, the next generation sequencing has allowed many advances in the characterization and quantification of transcripts in genome-wide manner. In particular, …
-
Characterising a novel tumour suppressor in liver cancer
Liver cancer is among the leading causes of cancer mortality worldwide, with hepatocellular carcinoma (HCC) accounting for 75-90% of primary liver cancers. In the United Kingdom, HCC incidences have risen by 167% since the 1990s, paralleling increases in alcohol use, obesity, diabetes, smoking, …
-
Predicting liver cancer on epigenomics data using machine learning
… being executed. These alterations arise in the cancer cells, which is the only cause of cancer. In this research, the objective is to propose a solution for the identification of the best genes of Liver Cancer from gene expression. Four different types of data are used in this research to …
-
Establishment of transgenic zebrafish model for liver cancer studies
<P>WE USED ZEBRAFISH AS AN ANIMAL MODEL FOR LIVER CANCER RESEARCH. SEVERAL STABLE TRANSGENIC ZEBRAFISH LINES WERE SUCCESSFULLY GENERATED TO EXPRESS SEVERAL ONCOGENES SPECIFICALLY IN THE LIVER/SKIN USING THE GAL4/UAS SYSTEM. THESE ONCOGENES INCLUDED C-MYC, HEPATITIS B VIRUS X GENE, WOODCHUCK …
-
Liver cancer chemoprevention : transcriptional regulation of AKR7A1 dietary chemoprevention
… certain chemoprotective agents can protect the liver from hepatocarcinogenesis initiated by aflatoxin B1 through up-regulating the expression of genes encoding protective enzymes. This is mediated through the transcription factor Nrf2 binding to an antioxidant response element (ARE) in the …
-
Ultra-Processed Food Consumption and Risk of Liver Cancer
… and type 2 diabetes, two risk factors for liver cancer. However, the relationship between UPF intake and liver cancer has scarcely been studied. We aimed to evaluate the association between UPF intake and the risk of liver cancer in three prospective cohorts and further explore the role of …
-
Dissecting the roles of glycerol metabolism in liver cancer
Liver cancer is the third leading cause of cancer-related mortality and has an increasing incidence worldwide. Despite of its poor prognosis the therapeutic options are limited, highlighting the need for new therapeutic strategies.<br/><br/>Cancer cells need a constant supply of energy, and …
-
Analysis of different intrahepatic progression patterns in liver cancer
… brachytherapy do not consider the underlying cancer entity and little is known about its sensitivity to malignancy to brachytherapy. The aim of this study was to use vertical multi-parameter MRI to carry out the survival conclusions of hepatocellular carcinoma (HCC) and colorectal cancer liver …
-
Crosslinked microspheres as drug delivery system for liver cancer
… (1,25 (OH)2VD3) can inhibit the proliferation of cancer cells including colorectal and hepatocellular cells which are mainly responsible for liver cancer. However, the use of 1, 25 (OH)2VD3 is hampered due to the development of hypercalcaemia. Current treatment using hepatic arterial delivery of …
-
Oncolytic vaccinia virus for the treatment of liver cancer
Aims: Current treatment of colorectal cancer (CRC) liver metastases has a success rate of 50% 5-year survival, and recurrence rates of 50%. There is therefore still a need for a novel treatment modality. We aimed to examine the ability of JX-594 to preferentially replicate in and kill CRLM in vitro …
-
Structural evolution of lipid droplets in murine liver cancer
Submission original under an indefinite embargo labeled 'Open Access'. The submission was exported from vireo on 2024-03-01 without embargo terms
-
Functions of deleted in liver cancer (DLC1) in cell dynamics
Combining proteomics, biochemical, structural and cellular studies, our current work had identified the eukaryote elongation factor 1A1 (EF1A1) as a novel interacting partner for the SAM domain of DLC1, defined their interaction mechanism through identifying important motif/domain involved for …
Page 1 of 28